Key result
Low-to-moderate pre-pregnancy cardiovascular health is linked to a ~161% higher risk of hypertensive pregnancy disorders.
Why the study?
Cardiovascular health before pregnancy may influence maternal and pregnancy outcomes, but evidence among women undergoing frozen embryo transfer remains limited.
Does low-to-moderate pre-pregnancy cardiovascular health increase the risk of adverse pregnancy outcomes in women undergoing frozen embryo transfer?
Cohort (n=1,521)
Does low-to-moderate pre-pregnancy cardiovascular health increase the risk of adverse pregnancy outcomes in women undergoing frozen embryo transfer?
Low-to-moderate pre-pregnancy cardiovascular health is associated with significantly increased risks of adverse pregnancy outcomes, including hypertensive disorders and gestational diabetes, in women undergoing frozen embryo transfer.
Pre-pregnancy CVH may inform FET counseling; hypothesis-generating for prospective trials on optimization.
Background Cardiovascular health before pregnancy may influence maternal and pregnancy outcomes; however, evidence among women undergoing frozen embryo transfer (FET) remains limited. Objective This retrospective cohort study aims to investigate the association between pre‐pregnancy biomedical cardiovascular health (CVH), defined by the American Heart Association, and adverse pregnancy outcomes (APOs) after FET. Methods This retrospective cohort study was conducted from January 2019 to August 2023 and included 1521 women undergoing FET in their first in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI) cycle. The main APOs included hypertensive disorders of pregnancy (HDP), gestational diabetes mellitus (GDM), preterm birth (PTB), offspring being large for gestational age (LGA) and small for gestational age (SGA). Modified Poisson regression models with restricted cubic splines were used to investigate the relationship between biomedical CVH and APOs, and adjusted population‐attributable fraction (PAF) and partial population‐attributable fraction(partial PAFs) models were used to quantify the theoretical reduction in APOs with CVH improvement. Results Compared with the high CVH group, the low‐to‐moderate CVH group was associated with higher risks of HDP (relative risk [RR] 2.61, 95% confidence interval [CI] 1.83, 3.73), GDM (RR 1.82, 95% CI 1.40, 2.38), PTB (RR 2.03, 95% CI 1.47, 2.81), and LGA (RR 1.28, 95% CI 1.08, 1.52). CVH was linearly associated with the log risk of HDP and PTB. In contrast, CVH showed nonlinear associations with the log risk of GDM and LGA. PAF estimates suggest that 11.0%–36.1% of these APOs could be associated with low‐to‐moderate CVH (CVH score < 80). Specifically, for individual CVH components, elevated blood pressure was the leading risk factor for HDP, whereas overweight and obesity (BMI) were the strongest risk factors for GDM, PTB, and offspring LGA. Conclusions Biomedical CVH is negatively associated with APOs in pregnancies after FET. Women undergoing FET might benefit from preventive strategies to improve CVH, especially BMI and blood pressure.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2026) conducted a cohort in Adverse pregnancy outcomes after frozen embryo transfer (n=1,521). Low-to-moderate pre-pregnancy biomedical cardiovascular health vs. High cardiovascular health was evaluated on Hypertensive disorders of pregnancy (HDP) (RR 2.61, 95% CI 1.83-3.73). Low-to-moderate pre-pregnancy cardiovascular health was associated with higher risks of hypertensive disorders of pregnancy (RR 2.61; 95% CI 1.83-3.73), gestational diabetes, and preterm birth.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: